New Drug Claimed to be Better Than Warfarin

by Kathy Jones on  August 29, 2011 at 6:56 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Bristol-Myers Squibb revealed that its new drug for stroke currently being developed in association with Pfizer has shown to be better than warfarin according to the results from their latest trial.
 New Drug Claimed to be Better Than Warfarin
New Drug Claimed to be Better Than Warfarin

Lead investigator for the trial, Dr Christopher Granger revealed that the drug, known as apixaban, performed "significantly better" than warfarin in the Phase III trial. According to the trial, apixaban reduced the risk of stroke by more than 21 percent when compared with warfarin.

The researchers went on to add that those who took apixaban had fewer stroke and major bleeding events and were also less likely to die compared to warfarin. The drug also reduced the risk of bleeding by 31 percent.

"There is an enormous unmet need in terms of treatment of patients at risk for stroke associated with atrial fibrillation. Only about half of patients who should be treated are being treated. The disparity exists because warfarin treatment has several limitations", the researchers said in a statement.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Clinical Trials - Different Phases of the trial Signature Drug Toxicity Anticoagulants Deep Vein Thrombosis Pulmonary Embolism 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive